Covered recipient · General Payments record
TROY H DILLARD
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$24,754.23
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $623.33 | 22 |
| Education | $32.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BETA BIONICS, INC. | $198.07 | 4 |
| Medtronic, Inc. | $132.20 | 6 |
| Novo Nordisk AS | $86.00 | 4 |
| Amgen Inc. | $57.69 | 2 |
| DEXCOM, INC. | $57.67 | 2 |
| Tandem Diabetes Care, Inc. | $32.88 | 1 |
| Astellas Pharma US Inc | $31.50 | 1 |
| Lilly USA, LLC | $29.38 | 1 |
| Amphastar Pharmaceuticals, Inc. | $16.49 | 1 |
| Xeris Pharmaceuticals, Inc. | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $27.39 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115576707 | CMS |
| Amgen Inc. | $30.30 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115576716 | CMS |
| Amphastar Pharmaceuticals, Inc. | $16.49 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149959288 | CMS |
| Astellas Pharma US Inc | $31.50 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139402589 | CMS |
| BETA BIONICS, INC. | $25.64 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087879659 | CMS |
| BETA BIONICS, INC. | $11.21 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087882511 | CMS |
| BETA BIONICS, INC. | $144.75 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087886231 | CMS |
| BETA BIONICS, INC. | $16.47 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087888299 | CMS |
| Dexcom, Inc. | $32.15 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153341843 | CMS |
| Dexcom, Inc. | $25.52 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153341845 | CMS |
| Lilly USA, LLC | $29.38 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135461354 | CMS |
| Medtronic, Inc. | $21.47 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119457975 | CMS |
| Medtronic, Inc. | $18.52 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119457977 | CMS |
| Medtronic, Inc. | $48.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119457979 | CMS |
| Medtronic, Inc. | $13.28 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119457981 | CMS |
| Medtronic, Inc. | $15.30 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119457983 | CMS |
| Medtronic, Inc. | $15.31 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119457985 | CMS |
| Novo Nordisk Inc | $18.67 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097277121 | CMS |
| Novo Nordisk Inc | $20.11 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096571564 | CMS |
| Novo Nordisk Inc | $32.27 | 11/14/2024 | Education | Undisputed | 01/23/2026 | 1097496281 | CMS |
| Novo Nordisk Inc | $14.95 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097018471 | CMS |
| Tandem Diabetes Care, Inc. | $32.88 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138747039 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.72 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144616367 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.